ARCHIVES

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Report to the Nation: Death Rates Continue To Decline Across All Major Disease Sites

January 3, 2014

Continous Hormone Therapy Superior To Intermittent In 17-Year SWOG Study

June 29, 2012

Lymphatic Mapping Techniques Can Outperform “Watch-and-Wait”

February 28, 2014

Fred Hutchinson Director Lee Hartwell To Retire Next Year; Board Begins Search

July 3, 2009

Panel Recommends 5-FU/Levamisole For Adjuvant Stage 3 Colon Cancer

April 27, 1990

Clinical Research PA In Lung Cancer Is Released

August 16, 1991